Blog – Cytonics Corporation

Skip to content Skip to footer

Cytonics Corporation

#64 ❤️‍🩹 Healthspan vs Lifespan The Future of Longevity with Cytonics

January 20, 20261KViews

#63 🌱 Don’t Plant Seeds in a Firestorm: Why Recent Stanford Article Validates Cytonics DMOAD Approach

January 6, 20261KViews

#62 🙏 Another Year Full of Gratitude

December 26, 20251KViews

#62 🙏 Another Year Full of Gratitude

December 26, 2025676Views

#61 🛑 Can We Stop Osteoarthritis Before It Starts?

December 20, 2025911Views

#60 👎 Where Big Pharma Tried And Failed

November 4, 20251KViews

#60 👎 Where Big Pharma Tried And Failed

November 4, 20251KViews

#59 🧬 Why is A2M being called a physiological guardian?

October 21, 2025934Views

#58 🚅 Inside the Engine Room: Progress Since Our $7M Raise

October 14, 2025775Views

#57: 👎 Why Cytonics Turned Down VC

August 27, 20251KViews

#56 🚗 Our CEO Delivers A Quick Message From the Road!

August 16, 20251KViews

#55 🧬 Perfecting Nature’s Blueprint

July 1, 20251KViews

#54 🌿 The Beauty of Nature’s Design

June 26, 20251KViews

#53 🧪 The Experiment That Started It All

June 25, 20251KViews

#52 🥊 Positioned to Win: Why Cytonics Stands Out in the 2025 Biotech Landscape

June 9, 20252KViews

#51 🥋 When Injury Meets Innovation: Rener Gracie’s Journey to Cytonics

June 1, 20251KViews

#50🔊Listen To Our CEO Describe Our Science In 40 Seconds

May 27, 20251KViews

#49 🦈 When a Shark Asks the Right Questions

May 14, 20252KViews

Cytonics Announces Initiation Of First-In-Human Phase 1 Clinical Study For CYT-108 In Patients Suffering From Osteoarthritis Of The Knee

April 22, 20253KViews

Cytonics Announces Completion Of Enrollment For Phase 1 Clinical Study Evaluating CYT-108, A Novel Recombinant Protease Inhibitor, In Patients Suffering From Osteoarthritis Of The Knee

April 22, 20252KViews

Cytonics Announces Successful Completion of Phase 1 Study for First Nine Patients in CYT-108 Clinical Trial

April 22, 20252KViews

Cytonics Announces Launch of Regulation A+ Equity Crowdfunding Campaign to Fund Phase 2 Development

April 22, 20252KViews

#48 🎉Major Milestone: Last Patient Completes Phase 1 Clinical Trial

March 31, 20252KViews

#47 🪙Cytonics Announces Launch of Regulation A+ Equity Crowdfunding Campaign to Fund Phase 2 Development

March 25, 20251KViews

#46 📢 Critical Patent Issuance Protecting Lead Drug Candidate

March 8, 2025999Views

#45 🚨 Major Phase 1 Study Milestone Achieved!

January 17, 20252KViews

#44 🎉 Landmark Year For Cytonics: A 2024 Missive

January 1, 2025967Views